Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27
- 4 August 1995
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 269 (5224) , 682-685
- https://doi.org/10.1126/science.7624798
Abstract
The p27 mammalian cell cycle protein is an inhibitor of cyclin-dependent kinases. Both in vivo and in vitro, p27 was found to be degraded by the ubiquitin-proteasome pathway. The human ubiquitin-conjugating enzymes Ubc2 and Ubc3 were specifically involved in the ubiquitination of p27. Compared with proliferating cells, quiescent cells exhibited a smaller amount of p27 ubiquitinating activity, which accounted for the marked increase of p27 half-life measured in these cells. Thus, the abundance of p27 in cells is regulated by degradation. The specific proteolysis of p27 may represent a mechanism for regulating the activity of cyclin-dependent kinases.Keywords
This publication has 26 references indexed in Scilit:
- Ubiquitin, proteasomes, and the regulation of intracellular protein degradationPublished by Elsevier ,2002
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Ubiquitin is attached to membranes of baculovirus particles by a novel type of phospholipid anchorCell, 1995
- The ubiquitin-proteasome proteolytic pathwayCell, 1994
- THE UBIQUITIN-CONJUGATION SYSTEMAnnual Review of Genetics, 1992
- Proteolysis, proteasomes and antigen presentationNature, 1992
- Association of cdk2 Kinase with the Transcription Factor E2F During S PhaseScience, 1992
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990
- Control of programmed cyclin destruction in a cell-free system.The Journal of cell biology, 1989
- Control of globin synthesis: The role of hemeJournal of Molecular Biology, 1972